T1	Outcomes 586 619	counts of most lymphocyte subsets
T2	Outcomes 704 715	CD4 T cells
T3	Outcomes 808 833	CD45RA(low/-)CD4 T cells;
T4	Outcomes 863 881	phytohemagglutinin
T5	Outcomes 886 939	herpesvirus antigen-stimulated proliferation, T cells
T6	Outcomes 968 996	appeared equally functional.
T7	Outcomes 997 1020	Median serum IgG levels
T8	Outcomes 1026 1033	similar
T9	Outcomes 1055 1100	rate of definite infections after engraftment
T10	Outcomes 1157 1240	rate of severe (inpatient treatment required) definite infections after engraftment
T11	Outcomes 1297 1343	difference in the rates of definite infections
T12	Outcomes 1348 1356	greatest
T13	Outcomes 1380 1392	intermediate
T14	Outcomes 1423 1429	lowest
T15	Outcomes 1452 1541	Death associated with a fungal or bacterial infection occurred between day 30 and day 365
T16	Outcomes 1686 1710	lymphocyte-subset counts
T17	Outcomes 1747 1758	infections.
